IPO market

Unlisted Ideas

Invest in Pre-IPO shares

IPO Ideas

Invest in IPO in just 3 clicks

About Us

Asston Pharmaceuticals IPO subscription

BBSMEBSEListed

Listed at

119

3.25%

Asston Pharmaceuticals IPO is a SME book building IPO. Price band is ₹123 per share. Minimum investment is ₹2.46 L. Lot size is 1000 shares. Open from 9 Jul 2025 to 11 Jul 2025. Allotment on 14 Jul 2025. Listing on 16 Jul 2025 at BSE. Managed by Sobhagya Capital Options Ltd Registrar: Maashitla Securities Private Limited. Key details for GMP, subscription, price, allotment, and listing in one place.

Live IPO subscription for Asston Pharmaceuticals IPO across categories. Total demand ₹27.87 Cr vs offered ₹21.28 L.

Official documents: RHP and DRHP.

Follow the latest IPO & unlisted research on iOS and Android.

Google Play App Store

Asston Pharmaceuticals IPO subscription

BBSMEBSEListed

Listed at

119

3.25%

Live IPO subscription for Asston Pharmaceuticals IPO across categories. Total demand ₹27.87 Cr vs offered ₹21.28 L.

Official documents: RHP and DRHP.

Subscription Status

Category	Offered	Placed	Times
QII	10,60,000	3,64,49,000	34.39
NII	3,22,000	11,38,26,000	353.50
NII (>10L)	2,15,000	9,12,62,000	424.47
NII (<10L)	1,07,000	2,25,64,000	210.88
Retail	7,46,000	12,84,16,000	172.14
Total	27,86,91,000	21,28,000	130.96

Application Wise Subscription

Category	Offered	Placed	Times
HNI (>10L)	69	0	0.00
HNI (3-10L)	35	7,522	214.91
Retail	373	64,208	172.14
Total	71,730	477	150.38

Asston Pharmaceuticals IPO subscription FAQs

How to read QIB / NII / Retail demand and what it implies.

What is the Asston Pharmaceuticals IPO subscription status?

The Asston Pharmaceuticals IPO subscription status shows how many times the issue has been subscribed across different investor categories such as QIB, NII (HNI), and Retail. It reflects the demand for the IPO during the subscription period.

Where can I check live Asston Pharmaceuticals IPO subscription numbers?

You can check live Asston Pharmaceuticals IPO subscription data on this page, which is updated based on official exchange data released during the IPO subscription period.

What are the investor categories in Asston Pharmaceuticals IPO subscription?

The Asston Pharmaceuticals IPO subscription is divided into the following categories: Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII / HNI), and Retail Individual Investors (RII). Each category has a separate quota and subscription data.

What does QIB subscription mean in Asston Pharmaceuticals IPO?

QIB subscription in Asston Pharmaceuticals IPO indicates the demand from institutional investors such as mutual funds, banks, and insurance companies.

What does NII or HNI subscription mean in Asston Pharmaceuticals IPO?

NII (also known as HNI) subscription in Asston Pharmaceuticals IPO represents bids from high-net-worth investors who apply for shares above the retail limit.

What does Retail subscription mean in Asston Pharmaceuticals IPO?

Retail subscription in Asston Pharmaceuticals IPO shows demand from individual investors who apply within the retail investment limit specified in the IPO details.

How often is Asston Pharmaceuticals IPO subscription data updated?

Asston Pharmaceuticals IPO subscription data is updated multiple times during market hours based on information published by stock exchanges.

Does higher Asston Pharmaceuticals IPO subscription guarantee allotment?

No, higher Asston Pharmaceuticals IPO subscription does not guarantee allotment. In case of oversubscription, allotment is done through a lottery system as per SEBI guidelines.

Is Asston Pharmaceuticals IPO subscription data official?

Yes, the subscription data shown for Asston Pharmaceuticals IPO is based on official data released by stock exchanges, but it may change during the day.

How does Asston Pharmaceuticals IPO subscription impact listing?

IPO subscription indicates demand, but the actual listing performance depends on market conditions, company fundamentals, and investor sentiment at the time of listing.